Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells

Inhibition of MEK/ERK activation attenuates autophagy and potentiates pemetrexed-induced activity against HepG2 hepatocellular carcinoma cells

(2015) Yongxi Tong et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Activation of G-protein coupled estrogen receptor inhibits the proliferation of cervical cancer cells via sustained activation of ERK1/2

(2015) Qiong Zhang et al.   CELL BIOCHEMISTRY AND FUNCTION

Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells

(2015) Yun Teng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo

(2015)   Oncotarget

Old, new and emerging functions of caspases

(2014) S Shalini et al.   CELL DEATH AND DIFFERENTIATION

Emerging trends in hepatocellular carcinoma incidence and mortality

(2014) Basile Njei et al.   HEPATOLOGY

Loss of Suppressors of Cytokine Signaling 3 Promotes Aggressiveness in Hepatocellular Carcinoma

(2014) Wen-Yong Wu et al.   JOURNAL OF INVESTIGATIVE SURGERY

Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor

(2014) Yun Teng et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Gender Effect in Experimental Models of Human Medulloblastoma: Does the Estrogen Receptor β Signaling Play a Role?

(2014) Alessandra Ciucci et al.   PLoS One

The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer

(2013) Ryan Chu et al.   CANCER

Obesity and Liver Cancer

(2013) Ester Vanni et al.   Clinics in Liver Disease

17β-Estradiol Suppresses the Macrophage Foam Cell Formation Associated with SOCS3

(2013) X. Liang et al.   HORMONE AND METABOLIC RESEARCH

Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells

(2013) B. Jammart et al.   JOURNAL OF VIROLOGY

Vascular endothelial growth factor regulates primate choroid-retinal endothelial cell proliferation and tube formation through PI3K/Akt and MEK/ERK dependent signaling

(2013) Jing Jin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease

(2013) Michael N. VanSaun et al.   PLoS One

The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization

(2013) C Wang et al.   Cell Death & Disease

GPER-1 acts as a tumor suppressor in ovarian cancer

(2013) Tanja Ignatov et al.   Journal of Ovarian Research

FXR ligands protect against hepatocellular inflammation via SOCS3 induction

(2012) Zhizhen Xu et al.   CELLULAR SIGNALLING

Adipocytokines and Hepatocellular Carcinoma

(2012) Verena Wieser et al.   DIGESTIVE DISEASES

Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology

(2012) Edward J. Filardo et al.   ENDOCRINOLOGY

Characterization of the G-protein-coupled membrane-bound estrogen receptor GPR30 in the zebra finch brain reveals a sex difference in gene and protein expression

(2011) Kalpana D. Acharya et al.   Developmental Neurobiology

Augmenting the Antitumor Effect of TRAIL by SOCS3 with Double-Regulated Replicating Oncolytic Adenovirus in Hepatocellular Carcinoma

(2011) Rui-Cheng Wei et al.   HUMAN GENE THERAPY

The G-protein-coupled estrogen receptor GPER in health and disease

(2011) Eric R. Prossnitz et al.   Nature Reviews Endocrinology

Expression of Wild-Type and Variant Estrogen Receptor Alpha in Liver Carcinogenesis and Tumor Progression

(2011) Vitale Miceli et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Peptide-based leptin receptor antagonists for cancer treatment and appetite regulation

(2010) Laszlo Otvos et al.   BIOPOLYMERS

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21 and induction of G2 cell-cycle arrest

(2010) Q K Y Chan et al.   CELL DEATH AND DIFFERENTIATION

Estrogen receptor β and the progression of prostate cancer: role of 5α-androstane-3β,17β-diol

(2010) Donatella Dondi et al.   ENDOCRINE-RELATED CANCER

17β-estradiol inhibits the production of infectious particles of hepatitis C virus

(2010) Kazumi Hayashida et al.   MICROBIOLOGY AND IMMUNOLOGY

Estrogen Receptor Subtypes in Ovarian Cancer

(2010) Karen K. L. Chan et al.   OBSTETRICS AND GYNECOLOGY

Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway

(2009) Yin-Yan He et al.   CANCER SCIENCE

ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence

(2009) Sebastien Cagnol et al.   FEBS Journal

ROS-mediated p38α MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A2-treated U937 cells

(2009) Wen-Hsin Liu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line

(2008) Ewelina Motylewska et al.   CANCER LETTERS

High Dose 17 β-Estradiol and the α-Estrogen Agonist PPT Trigger Apoptosis in Human Adrenal Carcinoma Cells but the β-Estrogen Agonist DPN Does Not

(2008) L. Prieto et al.   HORMONE AND METABOLIC RESEARCH

MAPK regulate p53-dependent cell death induced by benzo[a]pyrene: Involvement of p53 phosphorylation and acetylation

(2008) T. Lin et al.   TOXICOLOGY